White Papers

An Innovation Roadblock: The Shrinking Availability of Venture Capital in MedTech

Posted by | Fuld + Company

The medical device sector, like many health segments, is driven by the usual suspects: a growing elderly population, rising prevalence of debilitating diseases, increased importance on quality-of-life, and innovation through painstaking research and development (R&D) efforts.

R&D is the only factor that industry players have any influence over and presents significant potential to cause a paradigm shift in the medical device innovation we introduce and overall, how we approach the treatment and management of diseases via MedTech. By extension, innovation, whether in technological hardware or software or other key elements, could drive explosive growth across numerous product segments. What’s the challenge, then? In a word: funding.

Our health + life science consulting group investigated why innovation is stymied by lack of funding. Download the whitepaper to learn more.

Download the Whitepaper:



Tags: , , , , ,

Related Resources

Read More

Scenario Planning For the Post-COVID World – White Paper

While we can’t predict the future, we can consider a range of realistic possibilities with a structured scenario planning framework.

Read More

Exploring the Impact of COVID-19 on Strategy, Insights and Intelligence Professionals

Fuld + Company surveyed Strategy, Insights, and Intelligence (SI&I) professionals to better understand how the Covid-19 pandemic and associated economic […]

Read More

Fuld + Company’s Initial Perspectives on the Impact of Covid-19: Emerging Opportunities Across Industries

After several weeks of observing and examining the actions of businesses, government and other participants in the U.S economy, Fuld […]

Subscribe to our mailing list for our latest updates: